Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 9:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1153–1176 of 1,748 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Risks Clear all

Conditions: Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic
Interventions: Clazakizumab, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 30
States / cities: Huntsville, Alabama • Tucson, Arizona • Glendora, California + 24 more

Conditions: Cardiovascular Disease
Interventions: Yoga, Walking, Healthy Lifestyles Education; Other
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 375 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Acute Coronary Syndrome, Chest Pain
Interventions: Observation unit care, coupled with cardiac MRI; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Hypercholesterolemia, Coronary Artery Disease, Dyslipidemia, Hypertension
Interventions: Direct-to-patient tailored cardiovascular risk message system; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 40 Years to 79 Years
Enrollment: 464 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Cardiovascular Complication, Chemotherapeutic Toxicity
Interventions: Cardio-oncology rehabilitation; Behavioral
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 0 Years to 21 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, Diabetes, Chronic Kidney Disease (CKD), Hypertension, Smoking, Myocardial Infarction (MI), Unstable Angina, Angina, Coronary Artery Disease (CAD), Stroke, Transient Ischemic Attack (TIA), Carotid Stenosis, Peripheral Arterial Disease, Atherosclerosis, Claudication
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 7,658 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 14
States / cities: Little Rock, Arkansas • San Pedro, California • Ventura, California + 11 more

Conditions: Osteoporosis, Cardiovascular Risk Factor
Interventions: Yoga group; Behavioral
Lead sponsor: University of Massachusetts, Lowell; Other
Eligibility: 30 Years to 48 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Lowell, Massachusetts

Conditions: Immune System, Stress, Chronic Stress, Cardiovascular Health
Interventions: Peanuts, roasted, salted with skins, Isocaloric food; Other
Lead sponsor: USDA, Western Human Nutrition Research Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Davis, California

Conditions: Cardiovascular Disease Risk Reduction, Chronic Stress, Anxiety, Emotional Regulation, Hypertension Prevention, Health Disparities
Interventions: HRV Biofeedback Training; Behavioral
Lead sponsor: Amelia Saul, PhD, CTRS, BCB; Other
Eligibility: 18 Years to 35 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Acute Myocardial Infarction
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 75 Years and older
Enrollment: 3,042 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 81
States / cities: Fort Smith, Arkansas • Los Alamitos, California • Sacramento, California + 70 more

Conditions: Cardiovascular Diseases, Dietary Modification
Interventions: Red Meat Restricted, Red Meat Rich; Other
Lead sponsor: Purdue University; Other
Eligibility: 30 Years to 69 Years
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Atherosclerosis, Hypercholesterolemia
Interventions: Statins, HMG CoA; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 50 Years to 99 Years
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Disease
Interventions: Strawberry Meal, Control Meal; Dietary Supplement
Lead sponsor: Penn State University; Other
Eligibility: 20 Years to 50 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Hereditary Hemorrhagic Telangiectasia
Interventions: Not listed
Lead sponsor: Unity Health Toronto; Other
Eligibility: Not listed
Enrollment: 2,272 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2025
U.S. locations: 14
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 11 more

Conditions: Venous Thromboembolism
Interventions: Not listed
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 3 Months to 12 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 10
States / cities: La Jolla, California • San Diego, California • New Haven, Connecticut + 7 more

Conditions: Prostate Cancer
Interventions: No intervention; Other
Lead sponsor: Bayer; Industry
Eligibility: 55 Years and older · Male only
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Whippany, New Jersey

Conditions: Cardiovascular Risk Factor
Interventions: Choline, Placebo; Dietary Supplement
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Blacksburg, Virginia

Conditions: Vitamin D Status, Glucose Tolerance, Blood Pressure, Bone Mineral Density, Hyperlipidemia
Interventions: Vitamin D; Other
Lead sponsor: Baltimore VA Medical Center; Federal
Eligibility: 45 Years to 85 Years
Enrollment: 362 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Heart Failure Risk Factors in Healthy Individuals
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 1,208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2027
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Endometriosis
Interventions: Salsalate Pill, Placebo; Drug
Lead sponsor: Penn State University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Heart Failure, Diabetes
Interventions: Message with EchoGo, Standard Message; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: Not listed
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Coronary Artery Disease, Genetic Predisposition to Disease
Interventions: Genetic Risk Score for Coronary Artery Disease; Other
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 40 Years to 60 Years
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Chandler, Arizona • Gilbert, Arizona • Phoenix, Arizona

Conditions: Atherosclerosis, Cardiovascular Disease, Inflammation, Insulin Resistance, Noninsulin-dependent Diabetes Mellitus
Interventions: Salsalate, Placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 21 Years to 75 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Multiple Myeloma
Interventions: Cilta-cel, Talquetamab, Daratumumab, Teclistamab, Bortezomib, Lenalidomide, Dexamethasone, Cyclophosphamide, Fludarabine; Drug
Lead sponsor: Janssen Research & Development, LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 5
States / cities: Duarte, California • San Francisco, California • Iowa City, Iowa + 2 more

Search by objective public record fields.

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Effects of Health Promoting Programs on Cardiovascular Disease Risk

Cost Comparison of Cardiac Magnetic Resonance Imaging (MRI) Use in Emergency Department (ED) Patients With Chest Pain

Tailored Communication to Reduce Cardiovascular Risk

At-Home Cardiac Rehabilitation for Adolescents at Risk for Heart Failure

Patient and Provider Assessment of Lipid Management Registry

Effects of a 12-week Home-based Yoga on Bone and Cardiovascular Health

Impact of Peanut Consumption on Stress, Immune Function, Inflammation, and Cardiovascular Health in High-Stress Individuals

Improving Minority Health Through Biofeedback and Stress Reduction

SILVER-AMI: Outcomes in Older Persons With Heart Attacks

The Lean Meats Mediterranean Diet Study

Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression

Effect of Strawberries on Cardiovascular Disease Risk

Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia

A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide

Choline Supplementation and Cardiovascular Health

Vitamin D Retrospective Study and Role With Disease

Cleveland Heart and Metabolic Prevention Study

Endometriosis and Microvascular Dysfunction: Role of Inflammation

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

Genetic Risk Stratification for Primary Prevention of CAD in Men and Pre & Post-menopausal Women

Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk

A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma